OppenheimerFunds’s Asensus Surgical, Inc. ASXC Stock Holding History

OppenheimerFunds’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,020	Closed	-$77K	–	1871
2018 Q3	$77K	Buy	+1,020	New	+$69K	﹤0.01%	1806

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OppenheimerFunds's ASXC Position: Q4 2018 in Review

OppenheimerFunds sold out of Asensus Surgical, Inc. (ASXC) in Q4 2018, closing a stake of 1,020 shares — an estimated $77K sold.

OppenheimerFunds first reported a position in ASXC in Q3 2018 and held it in 1 quarter. The position peaked at $77K in Q3 2018. 150 funds tracked by Wall St. Rank hold ASXC as of Q4 2018.

OppenheimerFunds reported no remaining Asensus Surgical, Inc. position as of Q4 2018 after selling out during the quarter.
OppenheimerFunds sold 1,020 Asensus Surgical, Inc. shares in Q4 2018, an estimated $77K.
OppenheimerFunds first reported a position in Asensus Surgical, Inc. in Q3 2018 and held it in 1 quarter.
OppenheimerFunds's Asensus Surgical, Inc. position peaked at $77K in Q3 2018.
150 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2018.

Based on OppenheimerFunds's 13F filing for Q4 2018, filed 11 Feb 2019.